This image is not available for purchase in your country.

Anitviral Molnupiravir interfering in SARS-CoV-2 replication

Anitviral Molnupiravir interfering in SARS-CoV-2 replication

C054/3337

Rights Managed

50.1 MB (1.1 MB compressed)

3606 x 4860 pixels

30.5 x 41.1 cm ⏐ 12.0 x 16.2 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY

Caption

Illustration of antiviral drug Molnupiravir (spheres, centre) incorporating itself into SARS-CoV-2 RNA strand. Molnupiravir is a nucleoside analogue of cytidine and uridine. The drug is inserted into the RNA strand instead of cytidine or uridine. The coronavirus's proofreading enzymes that check for mutations do not recognise Molnupiravir has been inserted instead. This causes RNA polymerase (pink) to make faulty copies of the faulty RNA strand that can then only code for non-functional proteins. Molnupiravir has been approved for use in the UK for patients with moderate to mild Covid-19 with other risk factors such obesity, obesity, older age and diabetes mellitus.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • basket icon
  • Calculate price calculator icon
  • Add to board lightbox icon